Hunan Huateng Pharmaceutical Co., Ltd

Hunan Huateng Pharmaceutical Co., Ltd is a China-based startup that provides a one-stop CMDO for PEG derivatives and pharmaceutical molecules. The company, founded in 2013, has positioned itself as a key supplier for researchers and pharmaceutical companies, offering a wide range of products including intermediates, excipients, APIs, and reagents. With a strong team of over 400 full-time staff, including more than 160 professional researchers, of which approximately 60% hold Ph.D.'s and MSc's, Huateng Pharma has developed thousands of high-end biomedical products. The company boasts an extensive inventory of products available for immediate shipment and is also capable of undertaking production of new and known compounds upon customer order. Huateng Pharma has established partnerships with over 500 pharmaceutical companies worldwide, demonstrating a global reach in the industry. In addition, the company has made significant investments in its R&D capabilities, with a 5000 square meter R&D center equipped with advanced analytical and testing instruments and automatic reaction equipment, ensuring efficient completion of various customized orders from customers. This investment is further underlined by the company's commitment to growth, as evidenced by its investment of 300 million RMB in a 34,000 square meter industrial park with an annual capacity of more than 1 billion RMB in 2017. The industrial park is designed to integrate the production process and facilitate the complete transformation of lab-scale, pilot plant, and large-scale commercial production. The recent Venture Round investment received by Huateng Pharma on 21 December 2021 from Shenghong Fund further highlights the company's appeal to investors and its potential for continued growth and success within the Biopharma, Biotechnology, and Pharmaceutical industries.